Wibmer CK, Gorman J, Ozorowski G, Bhiman JN, Sheward DJ, Elliott DH, Rouelle J, Smira A, Joyce MG, Ndabambi N, Druz A, Asokan M, Burton DR, Connors M, Abdool Karim SS, Mascola JR, Robinson JE, Ward AB, Williamson C, Kwong PD, Morris L, Moore PL.
PLOS Pathogens 2017 January 13(1): e1006074.
Power RA, Parkhill J, de Oliveira T.
Nature Reviews Genetics 2017; 18(1):41-50.
Ntombela N, Mashamba-Thompson TP, Mtshali A, Voce A, Kharsany AB.
Systematic Reviews 2017; 6(1):9.
Dobra A, Bärnighausen T, Vandormael A, Tanser F.
AIDS 2017; 31(1):137-145.
Tanko RF, Soares AP, Müller TL, Garrett NJ, Samsunder N, Abdool Karim Q, Abdool Karim SS, Riou C, Burgers WA.
Journal of Immunology 2017; 198(3):1220-1228.
Chopera DR, Ntale R, Ndabambi N, Garrett N, Gray CM, Matten D, Abdool Karim Q, Abdool Karim SS, Williamson C.
AIDS 2017; 31(2):191-197.
CAPRISA was created in 2001 and formally established in 2002 under the NIH-funded Comprehensive International Program of Research on AIDS (CIPRA) by five partner institutions; University of KwaZulu-Natal, University of Cape Town, University of Western Cape, National Institute for Communicable Diseases, and Columbia University in New York. CAPRISA is a designated UNAIDS Collaborating Centre for HIV Prevention Research. The main goal of CAPRISA is to undertake globally relevant and locally responsive research that contributes to understanding HIV pathogenesis, prevention and epidemiology as well as the links between tuberculosis and AIDS care.